One anticipated advantage of DNA immunization is the potential to create multivalent vaccines. We have examined the effects of mixing plasmids into single formulations using plasmids expressing four different membrane bound glycoproteins from bovine herpesvirus-1 (BHV-1), bovine parainfluenzavirus-3 (bPI3) and human influenza virus (HINF). Plasmids were delivered by intradermal injection into the tails of mice and the types of responses generated were clearly affected by the expressed antigen. Plasmids expressing glycoproteins B and D of BHV-1, and the haemagglutinin/ neuraminidase of bPI3, generated responses with a predominance of IgG1, suggestive of a Th2 type of
Introduction
Immunization with plasmid DNA has been shown to be an effective method for generating protective immune responses to a number of pathogens (Hassett & Whitton, 1996 ; Manickan et al., 1997 ; Robinson & Torres, 1997) . DNA immunization involves the expression in vivo of antigens encoded by plasmids that are delivered typically either by intramuscular or by intradermal injection, or by a gene gun into the skin. DNA vaccines hold many possible advantages when compared with traditional vaccines (Hassett & Whitton, 1996 ; Whalen & Davis, 1995) . Immunization with DNA offers a safer vaccine than live or attenuated vaccines, as well as an ability to generate cell mediated responses, which subunit vaccines typically cannot. Other benefits of DNA vaccines include the potential for increased duration of immunity, an ability to immunize neonates, as well as low cost, high stability and ease of preparation.
One presumed advantage of DNA immunization is the potential for multivalent vaccines, in which several plasmids are mixed together in a single formulation. Unlike protein or viral vaccines that may require specific solubilizing conditions, possibly affecting other components of a multivalent vaccine, Author for correspondence : S. van Drunen Littel-van den Hurk.
Fax j1 306 9667478. e-mail vandenhurk!sask.usask.ca response. In contrast, the plasmid expressing HINF haemagglutinin induced an antibody response biased towards IgG2a, indicating a Th1 type of response. In most instances the mixing of plasmids had only slight effects on the magnitude or bias of the responses to the individual components. However, under certain conditions we found that addition of a second plasmid converted an IgG2a biased response to a response with primarily IgG1 antibody. The reverse situation (i.e. an IgG1 conversion to IgG2a), however, was not found. These findings have important implications for the development of multivalent vaccines.
there should be no physical incompatibilities between plasmids. However, interference at either the level of antigen production, or the response to antigen, is possible. Production of multivalent vaccines would be of great benefit in situations where repeated vaccination is too costly or cumbersome, such as with veterinary vaccines or vaccines for third world countries (Babiuk et al., 1998) . Several papers have described immunization with more than one type of plasmid (Gerdts et al., 1997 ; McClements et al., 1996) ; however, no detailed examination has been carried out on how the responses to individual components are affected by the mixing of plasmids. One recent report has shown that responses to individual plasmid encoded antigens may be altered by the administration of a second plasmid (Cardoso et al., 1998) . In this study we have used plasmids encoding four different viral membrane glycoproteins to examine, in detail, the compatibility of plasmids mixed for DNA immunization.
Methods
Plasmids. Genes for glycoproteins B and D from bovine herpesvirus-1 (BHV-1 gB and gD ; Tikoo et al., 1990 ; Whitbeck et al., 1988) , and the haemagglutinin\neuraminidase from bovine parainfluenzavirus-3 (bPI3-HN ; Suzu et al., 1987) were inserted into the pSLIA vector (Braun et al., 1997) creating plasmids pSLIAgB, pSLIAgD and pSLIAHN respectively. These plasmids have backbone sequences derived from pSL301 (Invitrogen) and the promoter from human cytomegalovirus (HCMV) including the intron A, and a 3h region of the bovine growth hormone (BGH) gene. The haemagglutinin from human influenza virus A\PR\8\34 (HINF-HA ; Young et al., 1983) was expressed from plasmid V1J-HA, which was a gift from D. Montgomery (Merck, West Point, PA, USA) and also uses the HCMV\intron A promoter and the BGH 3h region, but has a backbone sequence derived from pUC19 (Montgomery et al., 1993) . Plasmids pV1J-gD (BHV-1 gD in pUC19 background) and pSLIAHA (HINF-HA in pSL301) were created by exchanging the transcriptional units (promoter, gene and part of the BGH 3h region) from VIJ-HA and pSLIAgD.
Plasmids were grown in E. coli DH5α and purified by anion exchange resin (Qiagen). Concentration and purity were assessed spectrophotometrically, and constructs were confirmed by restriction enzyme digestion followed by agarose gel electrophoresis.
Animals. Plasmids in saline were injected in a single dose intradermally into two to four sites in the tails of C57Bl\6 mice (Charles River). Mice were bled at 2 weeks and 4 weeks, and then at monthly intervals for up to 20 weeks. All animal experiments were approved by the University Committee on Animal Care and Supply at the University of Saskatchewan.
ELISA. Antibody titres (either total or IgG subclass) were determined by ELISAs as described previously (Braun et al., 1997) and are represented as the optical density obtained from a given serum dilution. Appropriate dilutions were chosen so that the optical density values fell within the linear region of the titration curve. Endpoint titres of the responses were typically between 640-2560. For gB and gD specific ELISAs, in vitro synthesized recombinant forms of BHV-1 gB and gD (Kowalski et al., 1993 ; Li et al., 1996) were used to coat the plates. For the HN and HA specific ELISAs, virus purified on sucrose gradients was used. bPI3 virus was grown in Vero cells (Breker-Klassen et al., 1995) and influenza virus A\PR\8\34 was grown in fertile eggs (Hoskins, 1967) .
Statistical analyses of ELISA data were done using programs in the Sigmaplot software package (Jandel Scientific). An independent, two tailed t-test (P 0n05) was used to determine significant differences between the means of experimental groups.
Transfections. COS-7 cells were transfected using lipofectamine (Gibco-BRL) as described by the manufacturer. Surface antigen was detected by incubating unfixed, transfected cells with antiserum generated against the viral glycoproteins by DNA immunization, at 37 mC for 1 h. The cells were washed with PBS, pH 7n2, and incubated with an FITC-conjugated goat anti-mouse antiserum (Zymed) for a further 1 h at 37 mC. After washing the cells with PBS, the cells were examined under fluorescent light and labelling was compared with that of cells stained in a similar manner, but transfected with the null plasmid.
Results

Responses to individual plasmids
Initial experiments catalogued the magnitude and character of the serum antibody response to antigens expressed by the four different plasmids. Cell surface labelling of transfected COS-7 cells with specific antiserum confirmed that all of the plasmids produced proteins that were expressed on the cell surface (data not shown). The time-course of antibody production after injection of plasmids (Fig. 1 ) demonstrated that by 2-4 weeks the responses to pSLIAgD, pSLIAgB and pSLIAHN were all close to maximal with only slight increases occurring after this time. The response to V1J-HA, however, differed slightly with virtually no antibody present at 2 weeks Fig. 1 . Time-course of total serum antibody production in mice given single plasmid formulations. Antigen specific ELISAs were carried out with pooled serum from seven mice taken at various times after immunization. Values have been converted to % maximal response to harmonize the scale between the different ELISAs. W, pSLIAgB injected mice ; X, pSLIAHN injected mice ; $, pSLIAgD injected mice ; , V1J-HA injected mice. Mice were given a single dose of DNA into two sites with either 10 µg of pSLIAgB, pSLIAgD, V1J-HA, or 15 µg pSLIAHN. The total amount of DNA for each injection was made up to 30 µg with pSLIA. Serum dilutions used for ELISAs were 1/640. and only approximately 20 % of maximum at 4 weeks. All responses remained high for the duration of the experiment (20 weeks) with no decrease in titres found.
Two distinct types of responses were found in the mice injected with single types of plasmid DNA. BHV-1 gB and gD, and bPI3 HN antigens when expressed by plasmids generated CJGG Mixed DNA vaccines Mixed DNA vaccines responses with high levels of IgG1 and low levels of IgG2a (Fig. 2) . The ratio of IgG1 to IgG2a suggests a Th2 biased response. In contrast, antibodies generated against the HINF HA protein had high levels of IgG2a and low levels of IgG1, suggesting a Th1 type of response. Although serum antibody IgG1\IgG2a ratios are only indicators of a Th1 or Th2 type of response, in this experiment they clearly demonstrate a difference in the response to the HA antigen. Over the course of the experiment, IgG subclass biases did not change.
Backbone sequences have been found to affect immune responses under certain conditions. One known nucleotide sequence with immunomodulatory activity, AACGTT , occurs three times in the pSLIA vector and twice in V1J-HA. All the AACGTT sequences are in the ampicillin resistance genes and none occur within the different viral genes. Because the V1J-HA plasmid has a different backbone sequence, the genes from V1J-HA and pSLIAgD were exchanged, to ensure that plasmid backbone sequences (either AACGTT or other unknown sequences) were not responsible for the effects seen above. After a single intradermal injection of pV1J-gD and pSLIAHA plasmids, serum antibody levels in mice showed no significant differences in the magnitude, or the bias, of the response in comparison to the original plasmids (Fig. 2) . Thus, although effects of backbone sequences on immune responses have been documented (Roman et al., 1997 ; Sato et al., 1996) , they do not appear to be responsible for the differences in the IgG subclass distributions reported in this study.
Responses to plasmid mixtures
The effect of mixing plasmids, within a single vaccine, was then determined by examining the magnitudes and the IgG subclass of the antibody responses generated to the individual components of two-component or three-component vaccines. A single submaximal dose (5-20 µg) was used to ensure that any effects due to mixing were not hidden by an excess of injected DNA. Importantly, in all experiments null plasmid (pSLIA) was included, so that all injections contained equivalent amounts of total DNA. Total serum antibody responses measured by ELISAs are presented in Fig. 3 . Overall, only slight effects of mixing were found on the total antibody responses, with the trend suggesting slightly lower levels of antibody when plasmids were mixed. Any inhibition measured was typically equivalent to one fourfold endpoint titre, and is thus not excessively strong. The use of submaximal doses enhances variability between animals such that most apparent inhibition seen in Fig. 3 is not statistically significant. However, the consistency of the inhibition we have found over several experiments leads us to believe it is real, with the plasmid pSLIAgD showing the strongest inhibitory effect. For example, in all four separate experiments where pSLIAgD and pSLIAHN were mixed, HN-specific serum antibody levels were lower compared to immunization with a single plasmid, although twice the differences were not statistically significant (data not shown).
IgG subclass ratios also showed little effect from the mixing of plasmids (Table 1) . Since three of the four plasmids individually generated a IgG1 type response, it was not surprising that mixing of these plasmids did not alter the IgG bias. However V1J-HA, which generated a Th1 type response, maintained its IgG2a bias when mixed with the other plasmids, which themselves maintained their Th2 type of response.
One three-component formulation containing the pSLIAgD, pSLIAgB and V1J-HA plasmids was also tested.
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Table 1. IgG1/IgG2a ratios in serum from mice immunized with different plasmid mixtures
Values are the ratios of the OD values measures by ELISAs using subclass specific secondary antibodies at a 1\160 serum dilution. Primary plasmid denotes plasmid that expresses the antigen measured in ELISA. Mixed plasmids are the other components in the vaccine. The ' three-plasmid ' mix contains pSLIAgB, pSLIAgD and V1J-HA.
Mixed plasmids
Three Primary plasmid pSLIA pSLIAgD pSLIAgB pSLIAHN V1J-HA plasmids pSLIAgD 8n3 -8 n 2 7 n 8 1 0 6 n 2 pSLIAgB 2n9 2 n 2 -4 n 3 3 n 2 4 n 2 pSLIAHN 6n0 8 n 7 5 n 7 -2 n 5 -V1J-HA 0n22 0n71 0n3 0 n 1 -0 n 32 Total antibody responses (Fig. 3) and IgG subclass ratios (Table  1) suggest that the extra plasmid had no additional effect on the antibody responses. In the previous experiment, mixing of pSLIAgD and VIJ-HA seemed to show more pronounced effects on total antibody levels and the IgG1\IgG2a ratio than other mixtures (Fig. 3, Table 1 ). To extend these results, and test the limits of mixing plasmids, an experiment was carried out by injecting mice with combinations of high (20 µg) and low (5 µg) doses of pSLIAgD and VIJ-HA. With a 5 µg dose of VIJ-HA, addition of 5 µg of pSLIAgD to the mixture caused an increase in the relative amounts of IgG1 specific for HA (Fig. 4 A) . More significantly, 20 µg of pSLIAgD in the mixture caused a complete conversion in the ratio of serum IgG subclasses to a very strong IgG1 response. Serum from mice immunized with pSLIAgD alone did not bind influenza virus in the ELISA : thus the IgG1 antibodies are HA specific. With a 20 µg dose of VIJ-HA the same pattern was found where 5 µg of pSLIAgD enhanced the IgG1 ratio to approximately 1 : 1, and the 20 µg dose of pSLIAgD produced a ratio of 10 : 1 (data not shown). These results are consistent with the previous experiment in which pSLIAgD does appear to cause an alteration of the response to HA. In the final experiment the effect of pSLIAgD seems to be stronger, which may be due to experimental variations or because more total DNA was injected (40 µg in comparison to 30 µg) in the final experiment. Because the effects appear to be related to the dose of pSLIAgD, not the relative ratios of the two plasmids, it suggests that the strength of the IgG1 biased response may influence the conversion of the response. In mice given V1J-HA and 5 µg of pSLIAgD, the IgG1\IgG2a ratio of approximately 1 : 1 found for HA specific antibodies is a result of averaging values from individual mice. Individual mice, however, have typically either a predominant IgG1 or IgG2a subclass, not a balanced ratio. The results in Fig. CJGI 4 are therefore affected by the number of responders, and the number of mice that responded with a predominant IgG1 response are shown on the figure.
The reverse condition, i.e. the addition of V1J-HA to pSLIAgD, showed no effect on the IgG subclass ratios of the gD specific response, with all groups having a strong bias to a Th2 type of IgG subclass ratio (Fig. 4 B) .
Discussion
Multivalent vaccines represent a cost effective and simple method to generate protective immunity against multiple pathogens. Unfortunately, many vaccines cannot be mixed because of physical incompatibilities. DNA vaccines are thought to be ideal for multivalent vaccines because of their similarity of form. Experiments described in this paper represent the most comprehensive examination to date of the effects that may occur by mixing different antigen expressing plasmids.
One interesting feature of the antibody responses to the different antigens expressed alone was the difference in the IgG bias. The bias of the response to HA is consistent with previous work where a Th1 type of response was found with saline injection of V1J-HA (Feltquate et al., 1997) . As well, the Th2 type response to BHV-1 gD has been described (Braun et al., 1997) following intradermal injection of pSLIAgD. The method of plasmid delivery and the cellular localization of the expressed antigens are known to affect the bias of a response, presumably by altering the types of antigen presenting cells (APCs) that take up and process antigen (Feltquate et al., 1997) . In the present study, plasmid delivery and antigen localization were the same for the different antigens, suggesting that the antigen itself may influence the type of response. Although the proteins used in these experiments are membrane bound, they will transfer from the cells that have taken up the plasmid to APCs (Doe et al., 1996) . Because the antigens used in this study are viral membrane glycoproteins that are known to interact with extracellular receptors, the possibility thus exists that these viral antigens, if released from the cell, may target to different cell populations, creating the differences in the responses.
When plasmids were mixed there appeared to be a slight interference with the total antibody response in many instances. We believe that the inhibition may be a general low level of interference resulting from either reduced antigen production or antigen competition. As the amount of antigen expressed from cells increased, as would occur if two or more plasmids were mixed, the added burden on cellular resources, or potential problems of antigen toxicity, may reduce the efficiency of synthesis, and thus lower antigen load. As well, the increase of antigen produced by a multivalent vaccine could also cause increased competition for APCs. We have previously found that the relative efficacy of DNA immunization decreased with increasing amounts of DNA added (Braun et al., 1997) , which is consistent with these results. Because the cells responsible for the induction and perpetuation of the immune response to intradermally injected DNA are unknown, we are unable at this time to identify which factors may be responsible for the slight inhibition of the immune responses due to mixing plasmids.
Mixing of plasmids generally showed little effect on the antibody bias which is interesting, because the cytokine microenvironment during the initiation of the immune response in the lymph node is expected to dictate the type of response (Paul & Seder, 1994 ; Mosmann & Sad, 1996) . These data suggest a segregation of the antigens at some point, possibly as mentioned previously, because of targeting of antigens to different APCs. Although physical separation could be involved, a temporal difference may also be possible. In the response to V1J-HA, IgG2a antibody tended to be delayed in comparison to the IgG1 antibody generated to the other plasmids (Fig. 1, unpublished observation) . This raises the possibility that the antigen responses segregate in time, not space. Regardless of the exact mechanisms involved, the evidence suggests that DNA plasmids with different types of responses can be mixed and have little or no effect on the vaccine partners.
In contrast to examples described above, pSLIAgD, especially at higher doses, was found to cause a strong alteration in the response to V1J-HA. Presumably in this case the increased strength of the response to gD increased either the spatial or temporal distribution of Th2 type cytokines enough to influence the cytokine environment for the response to the HA protein. Cardoso et al. (1998) found a similar effect using plasmids encoding the HA and NP antigens from measles virus. They specifically showed that a Th2 biased response could alter a Th1 response. This is in contrast to several experiments in which DNA vaccines override the Th2 type of response to protein, and generate a Th1 response . These experiments were different, however, because plasmid DNA was mixed with protein and large amounts of DNA were used, so that backbone immunostimulatory sequences may have had an effect. In our experiments, and those of Cardoso et al. (1998) , plasmids were mixed and less DNA was used, such that the mechanisms for immune deviation likely differ from those in which plasmid and protein are mixed. Why a Th2 type of response dominates when plasmids are mixed is unknown, but it is of interest that the Th1 responses have little effect on the Th2 response. This result could give more credence to the possibility that there may be a temporal difference in the Th1 versus Th2 response. Thus, even if higher levels of V1J-HA plasmid are present, the effect of Th2 cytokines on IgG class switching during the response to pSLIAgD may precede the effect of Th1 cytokines.
In summary, our results indicate that there may be some effects of mixing plasmids, but this is dependent on the dose and on the specific antigen. In some situations it may be possible to mix plasmids and have little interference among the CJGJ R. Braun and others R. Braun and others components. However, under certain conditions responses may be altered by the other components of the vaccine. If protective immunity to a particular pathogen requires a specific type of response, induction of an inappropriate response may be detrimental. Conversely, mixing of plasmids could be used as a simple way to direct responses to certain components. It would appear, however, that Th2 type responses may be dominant. Data described in this paper indicate that multicomponent vaccines must be thoroughly tested to ensure appropriate responses. Because there are many factors that may influence a particular response including route, antigen, antigen form, dose and animal species, it is important to test multivalent vaccine candidates in the target species, ideally with a challenge model, such that the efficacy can be truly evaluated.
